» Articles » PMID: 34320343

Geographic Differences in Gut Microbiota Composition Impact Susceptibility to Enteric Infection

Overview
Journal Cell Rep
Publisher Cell Press
Date 2021 Jul 28
PMID 34320343
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Large-scale studies of human gut microbiomes have revealed broad differences in composition across geographically distinct populations. Yet, studies examining impacts of microbiome composition on various health outcomes typically focus on single populations, posing the question of whether compositional differences between populations translate into differences in susceptibility. Using germ-free mice humanized with microbiome samples from 30 donors representing three countries, we observe robust differences in susceptibility to Citrobacter rodentium, a model for enteropathogenic Escherichia coli infections, according to geographic origin. We do not see similar responses to Listeria monocytogenes infections. We further find that cohousing the most susceptible and most resistant mice confers protection from C. rodentium infection. This work underscores the importance of increasing global participation in microbiome studies related to health outcomes. Diverse cohorts are needed to identify both population-specific responses to specific microbiome interventions and to achieve broader-reaching biological conclusions that generalize across populations.

Citing Articles

Comparing the impact of landscape on the gut microbiome of Apis mellifera in Atlantic Forest and Caatinga Biomes.

Soares K, Da Rocha T, Hale V, Vasconcelos P, do Nascimento L, Silva N Sci Rep. 2025; 15(1):5293.

PMID: 39939365 PMC: 11822208. DOI: 10.1038/s41598-025-85114-y.


Integration of 168,000 samples reveals global patterns of the human gut microbiome.

Abdill R, Graham S, Rubinetti V, Ahmadian M, Hicks P, Chetty A Cell. 2025; 188(4):1100-1118.e17.

PMID: 39848248 PMC: 11848717. DOI: 10.1016/j.cell.2024.12.017.


An Update on Microbial Interventions in Autism Spectrum Disorder with Gastrointestinal Symptoms.

Moreno R, Ashwood P Int J Mol Sci. 2024; 25(23.

PMID: 39684788 PMC: 11641496. DOI: 10.3390/ijms252313078.


From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy.

Dora D, Szocs E, Soos A, Halasy V, Somodi C, Mihucz A Front Immunol. 2024; 15:1434804.

PMID: 39301033 PMC: 11410641. DOI: 10.3389/fimmu.2024.1434804.


Exploring and exploiting the rice phytobiome to tackle climate change challenges.

Hosseiniyan Khatibi S, Dimaano N, Veliz E, Sundaresan V, Ali J Plant Commun. 2024; 5(12):101078.

PMID: 39233440 PMC: 11671768. DOI: 10.1016/j.xplc.2024.101078.


References
1.
Hickey C, Kuhn K, Donermeyer D, Porter N, Jin C, Cameron E . Colitogenic Bacteroides thetaiotaomicron Antigens Access Host Immune Cells in a Sulfatase-Dependent Manner via Outer Membrane Vesicles. Cell Host Microbe. 2015; 17(5):672-80. PMC: 4432250. DOI: 10.1016/j.chom.2015.04.002. View

2.
Almeida A, Mitchell A, Boland M, Forster S, Gloor G, Tarkowska A . A new genomic blueprint of the human gut microbiota. Nature. 2019; 568(7753):499-504. PMC: 6784870. DOI: 10.1038/s41586-019-0965-1. View

3.
Zhong H, Ren H, Lu Y, Fang C, Hou G, Yang Z . Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics. EBioMedicine. 2019; 47:373-383. PMC: 6796533. DOI: 10.1016/j.ebiom.2019.08.048. View

4.
Zopf Y, Rabe C, Neubert A, Gassmann K, Rascher W, Hahn E . Women encounter ADRs more often than do men. Eur J Clin Pharmacol. 2008; 64(10):999-1004. DOI: 10.1007/s00228-008-0494-6. View

5.
Jacobson A, Lam L, Rajendram M, Tamburini F, Honeycutt J, Pham T . A Gut Commensal-Produced Metabolite Mediates Colonization Resistance to Salmonella Infection. Cell Host Microbe. 2018; 24(2):296-307.e7. PMC: 6223613. DOI: 10.1016/j.chom.2018.07.002. View